GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Jinxin Fertility Group Ltd (HKSE:01951) » Definitions » Cash Conversion Cycle

Jinxin Fertility Group (HKSE:01951) Cash Conversion Cycle : -27.75 (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Jinxin Fertility Group Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Jinxin Fertility Group's Days Sales Outstanding for the six months ended in Dec. 2023 was 10.45.
Jinxin Fertility Group's Days Inventory for the six months ended in Dec. 2023 was 11.81.
Jinxin Fertility Group's Days Payable for the six months ended in Dec. 2023 was 50.01.
Therefore, Jinxin Fertility Group's Cash Conversion Cycle (CCC) for the six months ended in Dec. 2023 was -27.75.


Jinxin Fertility Group Cash Conversion Cycle Historical Data

The historical data trend for Jinxin Fertility Group's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jinxin Fertility Group Cash Conversion Cycle Chart

Jinxin Fertility Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Conversion Cycle
Get a 7-Day Free Trial -34.03 -31.76 -26.15 -20.62 -26.67

Jinxin Fertility Group Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -22.46 -23.31 -23.05 -28.45 -27.75

Competitive Comparison of Jinxin Fertility Group's Cash Conversion Cycle

For the Medical Care Facilities subindustry, Jinxin Fertility Group's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jinxin Fertility Group's Cash Conversion Cycle Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Jinxin Fertility Group's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Jinxin Fertility Group's Cash Conversion Cycle falls into.



Jinxin Fertility Group Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Jinxin Fertility Group's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=10.35+14.28-51.3
=-26.67

Jinxin Fertility Group's Cash Conversion Cycle for the quarter that ended in Dec. 2023 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=10.45+11.81-50.01
=-27.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jinxin Fertility Group  (HKSE:01951) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Jinxin Fertility Group Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Jinxin Fertility Group's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Jinxin Fertility Group (HKSE:01951) Business Description

Traded in Other Exchanges
Address
No. 301, North Jingsha Road, Jinjiang District, Sichuan, Chengdu, CHN
Jinxin Fertility Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in providing IVF services in both China and the United States. The firm generates its revenue from Assisted reproductive services, management services, and ancillary medical services. Geographically, it generates a majority of its revenue from the People's Republic of China.
Executives
Jinxin Fertility Investment Group Limited 2101 Beneficial owner
Hrc Investment Holding, Llc
Hhlr Advisors, Ltd. 2102 Investment manager
Hhlr Fund, L.p. 2101 Beneficial owner
Morgan Stanley 2201 Interest of corporation controlled by you
Blackrock, Inc. 2201 Interest of corporation controlled by you
Hillhouse Capital Advisors, Ltd. 2102 Investment manager
Gaoling Fund, L.p. 2101 Beneficial owner

Jinxin Fertility Group (HKSE:01951) Headlines

No Headlines